Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL954993 | 0.93 | — | — | |
| Iodide SCHEMBL8245354 | 0.68 | — | — | |
| SCHEMBL955305 | 0.67 | — | — | |
| Iodide SCHEMBL299359 | 0.57 | — | — | |
| SCHEMBL1331208 | 0.57 | — | — | |
| SCHEMBL185 | 0.57 | — | — | |
| Iodide SCHEMBL6852940 | 0.57 | — | — | |
| SCHEMBL716666 | 0.51 | — | — | |
| SCHEMBL1241351 | 0.51 | — | — | |
| Phosphine SCHEMBL6243734 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200385374-A1 | IMIDAZOLE-BASED ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME | THE UNIVERSITY OF TOLEDO (US) | 2020-12-10 | — | — | US | claimed |
| WO-2019036607-A1 | IMIDAZOLE-BASED ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME | THE UNIVERSITY OF TOLEDO (US) | 2019-02-21 | — | — | WO | claimed |
| US-20260001903-A1 | ASCAROSIDE DERIVATIVES AND METHODS OF USE | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2026-01-01 | — | — | US | disclosed |
| US-20250367232-A1 | HALOGEN TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY | HUTCHINSON FRED CANCER RES (US) | 2025-12-04 | — | — | US | disclosed |
| US-12473323-B2 | Ascaroside derivatives and methods of use | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250282621-A1 | CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL L IGANDS | NANOCORE APS (DK) | 2025-09-11 | — | — | US | disclosed |
| US-20250188206-A1 | BIO-BASED ETHYLENE FOR THE PRODUCTION OF BIO-BASED POLYMERS, COPOLYMERS, AND OTHER BIO-BASED CHEMICAL COMPOUNDS | XYLECO, INC. | 2025-06-12 | — | — | US | disclosed |
| CN-119059879-A | Cyclopropanation of substituted olefins | 国际香料和香精公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-114423774-B | Ascaroside derivatives and methods of use | 加利福尼亚技术学院 | 2024-11-08 | — | — | CN | disclosed |
| CN-118382616-A | Synthesis method of complement factor D inhibitor and intermediate thereof | 阿雷克森制药公司 | 2024-07-23 | — | — | CN | disclosed |
| US-12016880-B2 | Halogen treatment of heart attack and ischemic injury | FRED HUTCHINSON CANCER CENTER (US) | 2024-06-25 | — | — | US | disclosed |
| US-4977265-A | WITH BACTERICIDAL ACTIVITY | HOFFMANN-LA ROCHE INC. (US) | 1990-12-11 | — | — | US | disclosed |
| US-4946847-A | BACTERICIDES | HOFFMANN-LA ROCHE INC. (US) | 1990-08-07 | — | — | US | disclosed |
| EP-0113561-B1 | PROSTAGLANDIN INTERMEDIATES, THEIR SYNTHESIS AND THEIR CONVERSION TO PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1989-03-15 | — | — | EP | disclosed |
| US-4806541-A | ANTIBACTERIAL AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1989-02-21 | — | — | US | disclosed |
| US-4549030-A | PROSTAGLANDIN DERIVATIVES | THE UPJOHN COMPANY (US) | 1985-10-22 | — | — | US | disclosed |
| US-4535173-A | Intermediates for the production of prostaglandins from D-glucose | THE UPJOHN COMPANY (US) | 1985-08-13 | — | — | US | disclosed |
| EP-0113561-A2 | Prostaglandin intermediates, their synthesis and their conversion to prostaglandins | THE UPJOHN COMPANY (US) | 1984-07-18 | — | — | EP | disclosed |
| US-4242332-A | 4,5-Methano-bufadienolide-rhamnosides, their preparation, and drugs containing these compounds | BASF AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| US-4022808-A | ZINC-ALUMINUM-TITANIUM-TIN-IRON OR GROUP 5A AS CATALYSTS | NIPPON SODA COMPANY LIMITED (JA) | 1977-05-10 | — | — | US | disclosed |